BMRA - BIOMERICA INC
3.4735
0.174 4.995%
Share volume: 117,908
Last Updated: 05-07-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$3.30
0.17
0.05%
View ratios
| Fiscal Date | 05-31-2023 | 08-31-2023 | 11-30-2023 | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 08-28-2024 | 10-15-2024 | 01-16-2024 | 04-12-2024 | 01-14-2025 | 10-15-2024 | 01-14-2025 | 04-14-2025 | |
| Total revenue | 1.109 M | 1.713 M | 1.567 M | 1.017 M | 1.118 M | 1.807 M | 1.636 M | 1.119 M | |
| Cost of revenue | 1.080 M | 1.301 M | 1.242 M | 1.166 M | 1.095 M | 1.518 M | 1.199 M | 1.100 M | |
| Gross profit | 29.000 K | 412.000 K | 325.000 K | -149.000 K | 23.000 K | 289.000 K | 437.000 K | 19.000 K | |
| 1,320.69% | -21.12% | -145.85% | 115.44% | 1,156.52% | 51.21% | -95.65% | |||
| Operating expenses | 1.865 M | 1.644 M | 1.933 M | 1.851 M | 1.550 M | 1.657 M | 1.430 M | 1.229 M | |
| Selling general and admin | 1.496 M | 1.172 M | 1.521 M | 1.508 M | 1.286 M | 1.360 M | 1.173 M | 1.012 M | |
| Research and development | 369.000 K | 472.000 K | 412.000 K | 343.000 K | 264.000 K | 297.000 K | 257.000 K | 217.000 K | |
| Total expenses | 1.865 M | 1.644 M | 1.933 M | 1.851 M | 1.550 M | 1.657 M | 1.430 M | 1.229 M | |
| -11.85% | 17.58% | -4.24% | -16.26% | 6.90% | -13.70% | -14.06% | |||
| Operating income | -1.836 M | -1.232 M | -1.608 M | -2.000 M | -1.527 M | -1.368 M | -993.000 K | -1.210 M | |
| Ebit | -1.836 M | -1.232 M | -1.608 M | -2.000 M | -1.527 M | -1.368 M | -993.000 K | -1.210 M | |
| Pretax income | -1.779 M | -1.109 M | -1.499 M | -1.914 M | -1.414 M | -1.312 M | -953.000 K | -1.167 M | |
| -37.66% | 35.17% | 27.69% | -26.12% | -7.21% | -27.36% | 22.46% | |||
| Income tax | 13.000 K | 23.000 K | 8.000 K | 4.000 K | 7.000 K | 4.000 K | -3.000 K | -4.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.792 M | -1.132 M | -1.507 M | -1.918 M | -1.421 M | -1.316 M | -950.000 K | -1.163 M | |
| 36.83% | -33.13% | -27.27% | 25.91% | 7.39% | 27.81% | -22.42% |
